Cite
Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency
MLA
Wasserman, Richard L., et al. Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulins for Primary Immunodeficiency. Oct. 2012. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..0ea0deb64f92e4812606dd8951460cdd&authtype=sso&custid=ns315887.
APA
Wasserman, R. L., Melamed, I., Stein, M. R., Gupta, S., Puck, J., Engl, W., Leibl, H., McCoy, B., Empson, V. G., Gelmont, D., Schiff, R. I., & Igsc, 10% with rHuPH20 Study Group. (2012). Recombinant human hyaluronidase-facilitated subcutaneous infusion of human immunoglobulins for primary immunodeficiency.
Chicago
Wasserman, Richard L, Isaac Melamed, Mark R Stein, Sudhir Gupta, Jennifer Puck, Werner Engl, Heinz Leibl, et al. 2012. “Recombinant Human Hyaluronidase-Facilitated Subcutaneous Infusion of Human Immunoglobulins for Primary Immunodeficiency,” October. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.dedup.wf.001..0ea0deb64f92e4812606dd8951460cdd&authtype=sso&custid=ns315887.